Search

Your search keyword '"Semplicini, A."' showing total 408 results

Search Constraints

Start Over You searched for: Author "Semplicini, A." Remove constraint Author: "Semplicini, A." Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
408 results on '"Semplicini, A."'

Search Results

1. User experience of passive hip flexion device in people with multiple sclerosis: Exploring improvements and overcoming barriers

2. Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD)

3. Ablation of collagen VI leads to the release of platelets with altered function

4. Stroke management during the coronavirus disease 2019 (COVID-19) pandemic: experience from three regions of the north east of Italy (Veneto, Friuli-Venezia-Giulia, Trentino-Alto-Adige)

5. Collagen VI deficiency causes behavioral abnormalities and cortical dopaminergic dysfunction

7. Targeted gene panel screening is an effective tool to identify undiagnosed late onset Pompe disease

8. European muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)

9. Assessing the Role of Anti rh-GAA in Modulating Response to ERT in a Late-Onset Pompe Disease Cohort from the Italian GSDII Study Group

10. Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease

13. Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study

14. Assessment of disease progression in dysferlinopathy: A 1-year cohort study

15. Critical issues in the relationships between patient relatives and hospital staff: qualitative research based on focus group

18. Who should be screened for secondary causes of hypertension?

20. Obsessive-Compulsive and Post Traumatic Avoidance Symptoms Influence the Response to Antihypertensive Therapy: Relevance in Uncontrolled Hypertension

24. Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy.

25. BURDEN, PROFESSIONAL SUPPORT, AND SOCIAL NETWORK IN FAMILIES OF CHILDREN AND YOUNG ADULTS WITH MUSCULAR DYSTROPHIES

26. “I have got something positive out of this situation”: psychological benefits of caregiving in relatives of young people with muscular dystrophy

28. Lack of COL6/collagen VI causes megakaryocyte dysfunction by impairing autophagy and inducing apoptosis.

31. Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years

35. Genome-wide association study identifies CAMKID variants involved in blood pressure response to losartan: the SOPHIA study

37. Syncope and sudden death from the emergency physician’s perspective: is there room for new biomarkers?

38. Therapeutic advances in the management of Pompe disease and other metabolic myopathies

39. The Renin-Angiotensin System, Capri 2005: Contributions from the VIII International Forum

40. Progress in enzyme replacement therapy in glycogen storage disease type II

Catalog

Books, media, physical & digital resources